Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRG
8376
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $538K | ﹤0.01% |
20,472
-60,638
| -75% | -$1.6M |
|
8377
PUT
AptarGroup
ATR
$8.38B
| $537K | ﹤0.01% |
5,200
-400
| -7% | -$43.6K |
|
8378
Harvard Bioscience
HBIO
$29.6M
| $537K | ﹤0.01% |
14,894
+12,884
| +641% | +$581K |
|
8379
iShares US Energy ETF
IYE
$1.84B
| $537K | ﹤0.01% |
14,100
+3,610
| +34% | +$153K |
|
8380
CALL
Ondas Inc
ONDS
$5.13B
| $537K | ﹤0.01% |
99,600
-100
| -0.1% | -$691 |
|
8381
PUT
Cullen/Frost Bankers
CFR
$10.4B
| $536K | ﹤0.01% |
4,600
+100
| +2% | +$12.8K |
|
8382
PUT
Healthpeak Properties
DOC
$14.2B
| $536K | ﹤0.01% |
+20,700
| New | +$627K |
|
8383
PUT
Greif
GEF
$4.97B
| $536K | ﹤0.01% |
8,600
-15,600
| -64% | -$953K |
|
8384
PUT
Hilltop Holdings
HTH
$2.25B
| $536K | ﹤0.01% |
+20,100
| New | +$573K |
|
8385
CALL
NeoGenomics
NEO
$2.08B
| $536K | ﹤0.01% |
65,800
-31,900
| -33% | -$305K |
|
|
NFBK
8386
DELISTED
Northfield Bancorp
NFBK
| $536K | ﹤0.01% |
+41,169
| New | +$540K |
|
8387
CALL
Tidewater
TDW
$4.68B
| $536K | ﹤0.01% |
25,400
+8,400
| +49% | +$193K |
|
8388
PUT
Essential Utilities
WTRG
$11.3B
| $536K | ﹤0.01% |
11,700
+3,900
| +50% | +$181K |
|
|
MMAT
8389
CALL
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $536K | ﹤0.01% |
5,207
+1,687
| +48% | +$252K |
|
|
SRC
8390
PUT
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $536K | ﹤0.01% |
14,200
+6,800
| +92% | +$286K |
|
8391
CALL
BGC Group
BGC
$5.31B
| $535K | ﹤0.01% |
158,800
-179,100
| -53% | -$624K |
|
8392
Tyra Biosciences
TYRA
$1.56B
| $535K | ﹤0.01% |
74,845
-3,464
| -4% | -$27.6K |
|
|
GRES
8393
DELISTED
IQ ARB Global Resources
GRES
| $535K | ﹤0.01% |
+17,338
| New | +$592K |
|
8394
Hingham Institution for Saving
HIFS
$663M
| $534K | ﹤0.01% |
+1,882
| New | +$591K |
|
8395
CALL
Invesco Energy Exploration & Production ETF
PXE
$84.9M
| $534K | ﹤0.01% |
+20,800
| New | +$622K |
|
8396
Veritone
VERI
$108M
| $534K | ﹤0.01% |
81,791
+51,262
| +168% | +$517K |
|
|
VRN
8397
CALL
DELISTED
Veren
VRN
| $534K | ﹤0.01% |
75,000
+34,500
| +85% | +$271K |
|
8398
CALL
Microvast
MVST
$310M
| $533K | ﹤0.01% |
240,300
-119,000
| -33% | -$511K |
|
|
NOTV
8399
DELISTED
Inotiv
NOTV
| $533K | ﹤0.01% |
55,512
-3,164
| -5% | -$53K |
|
8400
Artivion
AORT
$1.38B
| $532K | ﹤0.01% |
28,176
+2,679
| +11% | +$51.7K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.